Electrical Interactions in Heart Disease
- Conditions
- Cardiomyopathy, Dilated
- Registration Number
- NCT01508871
- Lead Sponsor
- University Health Network, Toronto
- Brief Summary
This study will evaluate the relationship of markers of cardiac activation and their determinants. The hypothesis is that these markers will be interrelated.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- ventricular dysfunction
Exclusion Criteria
- normal ventricular function
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie cardiac activation markers in dilated cardiomyopathy as studied in NCT01508871?
How do cardiac activation patterns in NCT01508871 compare to standard-of-care biomarkers for dilated cardiomyopathy prognosis?
Which biomarkers of cardiac activation correlate with disease progression in dilated cardiomyopathy according to NCT01508871 findings?
What adverse events are associated with cardiac activation monitoring techniques in observational heart disease studies like NCT01508871?
How might insights from NCT01508871 influence combination therapies targeting electrical remodeling in dilated cardiomyopathy?
Trial Locations
- Locations (1)
Mount Sinai Hospital
🇨🇦Toronto, Ontario, Canada
Mount Sinai Hospital🇨🇦Toronto, Ontario, CanadaVijay Chauhan, MDContact416-340-3172vijay.chauhan@uhn.on.ca